Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
118.30
+0.81 (0.69%)
Jul 11, 2025, 1:13 PM - Market open
Encompass Health Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$123.38
Upside
+4.29%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Reiterates $135 | Buy | Reiterates | $135 | +14.12% | Jun 5, 2025 |
Keybanc | Keybanc | Buy Maintains $122 → $135 | Buy | Maintains | $122 → $135 | +14.12% | May 27, 2025 |
UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +9.89% | Apr 28, 2025 |
RBC Capital | RBC Capital | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +5.66% | Apr 28, 2025 |
Truist Securities | Truist Securities | Strong Buy Reiterates $116 → $135 | Strong Buy | Reiterates | $116 → $135 | +14.12% | Apr 28, 2025 |
Keybanc | Keybanc | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +3.13% | Apr 25, 2025 |
Barclays | Barclays | Buy Maintains $118 → $129 | Buy | Maintains | $118 → $129 | +9.04% | Apr 25, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $110 | Buy | Reiterates | $110 | -7.02% | Feb 11, 2025 |
Keybanc | Keybanc | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +1.44% | Feb 10, 2025 |
Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | -0.25% | Feb 7, 2025 |
RBC Capital | RBC Capital | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | -7.02% | Oct 30, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $108 → $116 | Strong Buy | Reiterates | $108 → $116 | -1.94% | Oct 30, 2024 |
Barclays | Barclays | Buy Maintains $109 → $116 | Buy | Maintains | $109 → $116 | -1.94% | Oct 29, 2024 |
Keybanc | Keybanc | Buy Maintains $115 → $117 | Buy | Maintains | $115 → $117 | -1.10% | Oct 29, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $104 → $108 | Strong Buy | Maintains | $104 → $108 | -8.71% | Oct 14, 2024 |
Keybanc | Keybanc | Buy Initiates $115 | Buy | Initiates | $115 | -2.79% | Oct 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.